These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 6166768)

  • 1. [Alpha-fetoprotein as a tumor marker].
    Yachi A; Suga M
    Nihon Rinsho; 1980 Dec; 38(12):4554-9. PubMed ID: 6166768
    [No Abstract]   [Full Text] [Related]  

  • 2. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
    Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
    Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
    [No Abstract]   [Full Text] [Related]  

  • 3. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
    Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
    Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum AFP and AFP-L3 in clinically distinguished hepatocellular carcinoma from patients with liver masses.
    Subwongcharoen S; Leelawat K; Treepongkaruna SA; Narong S
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S46-51. PubMed ID: 21717878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-fetoprotein and hepatocellular carcinoma.
    Colli A; Fraquelli M; Conte D
    Am J Gastroenterol; 2006 Aug; 101(8):1939; author reply 1940-1. PubMed ID: 16928257
    [No Abstract]   [Full Text] [Related]  

  • 6. [What can be the cause of elevated alpha-fetoprotein after hydrocele surgery?].
    Reiner B
    Dtsch Med Wochenschr; 2002 Mar; 127(9):465. PubMed ID: 11870565
    [No Abstract]   [Full Text] [Related]  

  • 7. [Two patients with liver cirrhosis who presented with alpha-fetoprotein values diagnostic of hepatocarcinoma but without evidence of neoplasms].
    Cristani A; Borghi A; Cioni G; Vignoli A; Ventura E
    Recenti Prog Med; 1992 May; 83(5):286-7. PubMed ID: 1279760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum alpha-fetoprotein and hepatocellular carcinoma size.
    Piantino P; Fusaro A; Daziano E
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):131. PubMed ID: 2480412
    [No Abstract]   [Full Text] [Related]  

  • 9. Marked episodic elevations of alpha-fetoprotein without hepatocellular carcinoma in a patient with hepatitis B.
    Wong CB; Attar BM; Shimoda SS
    Am J Gastroenterol; 1995 Jun; 90(6):1015-6. PubMed ID: 7539578
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical significance of alpha-fetoprotein assay as a tumor marker].
    Endo Y; Iino S; Miyazaki J
    Nihon Rinsho; 1990 Feb; 48 Suppl():949-52. PubMed ID: 1693988
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatocellular carcinoma (HCC) and diagnostic significance of A-fetoprotein (AFP).
    Baig JA; Alam JM; Mahmood SR; Baig M; Shaheen R; Sultana I; Waheed A
    J Ayub Med Coll Abbottabad; 2009; 21(1):72-5. PubMed ID: 20364746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Golgi Phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
    Li X; Wu K; Fan D
    Hepatology; 2009 Jul; 50(1):325. PubMed ID: 19492428
    [No Abstract]   [Full Text] [Related]  

  • 13. [Alpha-fetoprotein in relation to the age of the subject. Normal and pathological levels].
    Hurjui J; Teodorovici I; Creţeanu M
    Rev Med Chir Soc Med Nat Iasi; 1980; 84(2):283-6. PubMed ID: 6164085
    [No Abstract]   [Full Text] [Related]  

  • 14. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
    Sato Y; Nakata K; Kato Y; Shima M; Ishii N; Koji T; Taketa K; Endo Y; Nagataki S
    N Engl J Med; 1993 Jun; 328(25):1802-6. PubMed ID: 7684823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Subject diagnostic value of detecting a1pha-fetoprotein variants with a new microspincolumn method in hepatocellular carcinoma].
    Xu AF; Wang MC; Sui DM; Yuan YH; Chen G; Lou GQ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):67-9. PubMed ID: 17429541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extreme elevation of serum alpha fetoprotein in decompensated cirrhosis without HCC: an ominous sign.
    Senturk H; Cumali R
    Int J Biol Markers; 2007; 22(1):19-23. PubMed ID: 17393357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunochemical determination of alpha-fetoprotein in the dynamics of development of liver cirrhosis and hepatocellular cancer].
    Afanas'eva KA; Ragozin IuE; Tatarinov IuS
    Vestn Akad Med Nauk SSSR; 1975; (6):71-3. PubMed ID: 58499
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical aspects of hepatocellular carcinoma in man.
    Desai HN
    S Afr Med J; 1976 Sep; 50(41):1611-3. PubMed ID: 62408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The des-gamma-carboxyprothrombin for the diagnosis of hepatocellular carcinoma.
    Brunello F; Marcarino C; Pasquero P; Gastaldi P; Gonella S; Martini S; Calcamuggi G; Emanuelli G
    Ital J Gastroenterol; 1993 Jan; 25(1):9-12. PubMed ID: 7679014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polycythemia as a paraneoplastic syndrome in hepatocellular carcinoma].
    Häufle M; Walker S; Bode JC
    Med Klin (Munich); 1994 Nov; 89(11):626-8. PubMed ID: 7815994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.